APTERNA LIMITED

Active London

Research and experimental development on biotechnology

5 employees website.com
Research and experimental development on biotechnology
A

APTERNA LIMITED

Research and experimental development on biotechnology

Founded 29 Mar 2011 Active London, United Kingdom 5 employees website.com
Research and experimental development on biotechnology

Previous Company Names

HCC RNA THERAPEUTICS LIMITED 29 Mar 2011 — 20 Aug 2013
Accounts Submitted 23 Dec 2025 Next due 31 Dec 2026 8 months remaining
Confirmation Submitted 8 Apr 2026 Next due 12 Apr 2027 11 months remaining
Net assets £-20K £24K 2024 year on year
Total assets £8K £49K 2024 year on year
Total Liabilities £28K £26K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

1 Vincent Square London SW1P 2PN

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for APTERNA LIMITED (07583272), an active company based in London, United Kingdom. Incorporated 29 Mar 2011. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2013–2024)

Cash in Bank

£7.77k

Decreased by £45.60k (-85%)

Net Assets

-£19.97k

Decreased by £23.73k (-630%)

Total Liabilities

£28.06k

Decreased by £25.66k (-48%)

Turnover

N/A

Employees

5

Debt Ratio

347%

Increased by 254 (+273%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 51,374 Shares £9669.90m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
3 Feb 20248,921£50k£5.6
2 Aug 201818,868£3773.60m£200k
2 Aug 201823,585£5896.25m£250k

Officers

Officers

3 active
Status
Doogan, Declan, DrDirectorBritishUnited States741 Oct 2015Active
Habib, Nagy, ProfessorDirectorBritishUnited Kingdom7329 Mar 2011Active
Habib, Robert SebastianDirectorBritishUnited Kingdom409 Oct 2014Active

Shareholders

Shareholders (14)

John Rossi
29.0%
371,214
Robert Habib
17.8%
227,412

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
8 Apr 2026Confirmation StatementConfirmation statement made on 2026-03-29 with no updates
23 Dec 2025AccountsAnnual accounts made up to 2025-03-31
16 Sept 2025AddressChange Registered Office Address Company With Date Old Address New Address
16 Sept 2025OfficersChange to director Robert Sebastian Habib on 2025-09-15
16 Sept 2025OfficersChange to director Dr Declan Doogan on 2025-09-15
8 Apr 2026 Confirmation Statement

Confirmation statement made on 2026-03-29 with no updates

23 Dec 2025 Accounts

Annual accounts made up to 2025-03-31

16 Sept 2025 Address

Change Registered Office Address Company With Date Old Address New Address

16 Sept 2025 Officers

Change to director Robert Sebastian Habib on 2025-09-15

16 Sept 2025 Officers

Change to director Dr Declan Doogan on 2025-09-15

Recent Activity

Latest Activity

Confirmation statement made on 2026-03-29 with no updates

1 weeks ago on 8 Apr 2026

Annual accounts made up to 2025-03-31

3 months ago on 23 Dec 2025

Change Registered Office Address Company With Date Old Address New Address

7 months ago on 16 Sept 2025

Change to director Robert Sebastian Habib on 2025-09-15

7 months ago on 16 Sept 2025

Change to director Dr Declan Doogan on 2025-09-15

7 months ago on 16 Sept 2025